Literature DB >> 24199705

Salvage esophagectomy in the management of recurrent or persistent esophageal carcinoma.

Jenifer Marks1, David C Rice, Stephen G Swisher.   

Abstract

Salvage esophagectomy is a viable treatment option in the management of recurrent or persistent esophageal cancer and can be performed with acceptable morbidity and mortality in a select group of patients. Patient selection should include a complete restaging evaluation, cardiopulmonary testing, and an assessment of functional status. A majority of patients with persistent or recurrent esophageal cancer are not candidates for salvage resection. Carefully selected patients undergoing a salvage resection can have outcomes similar to those undergoing a planned esophagectomy after definitive chemoradiotherapy.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adenocarcinoma; Chemotherapy; Esophagectomy; Radiation; Salvage; Squamous

Mesh:

Year:  2013        PMID: 24199705     DOI: 10.1016/j.thorsurg.2013.08.001

Source DB:  PubMed          Journal:  Thorac Surg Clin            Impact factor:   1.750


  1 in total

1.  MicroRNA-27a directly targets KRAS to inhibit cell proliferation in esophageal squamous cell carcinoma.

Authors:  Yuzhi Jiang; Yuting Duan; Haibin Zhou
Journal:  Oncol Lett       Date:  2014-11-11       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.